Amarnath Natarajan, PhD

Professor, Eppley Institute for Cancer Research
Courtesy Professor, Genetics, Cell Biology & Anatomy
Member, James O Armitage Center for Hematological Malignancies Research
Member, Fred & Pamela Buffett Cancer Center
Mentor, Center for Molecular Target Discovery & Development

Phone402-559-3793

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Amarnath Natarajan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
3 Finished

Development of Quinoxaline Based IKKbeta Inhibitors for Kras Driven Cancers
Natarajan, A.
National Institutes of Health
5/9/16 → 4/30/21
Project: Research project
Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer
Natarajan, A.
National Institutes of Health
1/1/14 → 12/31/16
Project: Research project
pBACH1 binding site on BRCT(BRCA1): A novel approach to cancer therapeutics
Natarajan, A.
National Institutes of Health
9/8/08 → 7/31/14
Project: Research project
HTS to Identify Small Molecule Inhibitors of Phospho-Specific Protein-Protein Int
Natarajan, A.
National Institutes of Health
6/1/07 → 5/31/09
Project: Research project

1641 Citations
25 h-Index
64 Article
4 Review article
2 Comment/debate
1 Letter
More
- 1 Short survey

EHD1 and RUSC2 control basal epidermal growth factor receptor cell surface expression and recycling
Tom, E. C., Mushtaq, I., Mohapatra, B. C., Luan, H., Bhat, A. M., Zutshi, N., Chakraborty, S., Islam, N., Arya, P., Bielecki, T. A., Iseka, F. M., Bhattacharyya, S., Cypher, L. R., Goetz, B. T., Negi, S. K., Storck, M. D., Rana, S., Barnekow, A., Singh, P. K., Ying, G. & 4 others, Guda, C., Natarajan, A., Band, V. & Banda, H., Apr 1 2020, In: Molecular and cellular biology. 40, 7, e00434.
Research output: Contribution to journal › Article › peer-review
2 Scopus citations
Erratum: Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy (Oncotarget (2018) 9 (5216-5232) DOI: 10.18632/oncotarget.23749)
Robb, C. M., Kour, S., Contreras, J. I., Agarwal, E., Barger, C. J., Rana, S., Sonawane, Y., Neilsen, B. K., Taylor, M., Kizhake, S., Thakare, R. N., Chowdhury, S., Wang, J., Black, J. D., Hollingsworth, M. A., Brattain, M. G. & Natarajan, A., Jun 23 2020, In: Oncotarget. 11, 25, p. 2462-2463 2 p.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access
Symbiotic prodrugs (SymProDs) dual targeting of NFkappaB and CDK
Rana, S., Kour, S., Sonawane, Y. A., Robb, C. M., Contreras, J. I., Kizhake, S., Zahid, M., Karpf, A. R. & Natarajan, A., Aug 1 2020, In: Chemical Biology and Drug Design. 96, 2, p. 773-784 12 p.
Research output: Contribution to journal › Article › peer-review
A mitotic CDK5-PP4 phospho-signaling cascade primes 53BP1 for DNA repair in G1
Zheng, X. F., Acharya, S. S., Choe, K. N., Nikhil, K., Adelmant, G., Satapathy, S. R., Sharma, S., Viccaro, K., Rana, S., Natarajan, A., Sicinski, P., Marto, J. A., Shah, K. & Chowdhury, D., Dec 1 2019, In: Nature communications. 10, 1, 4252.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
A simple fluorescent assay for the discovery of protein-protein interaction inhibitors
Al-Mugotir, M., Kolar, C., Vance, K., Kelly, D. L., Natarajan, A. & Borgstahl, G. E. O., Mar 15 2019, In: Analytical Biochemistry. 569, p. 46-52 7 p.
Research output: Contribution to journal › Article › peer-review
4 Scopus citations